Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Infectious Diseases|June 30, 2016
Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260sTheodoros Kelesidis, Carlee Moser, James H Stein, et al.
The Journal of Infectious Diseases|August 31, 2023
Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment TrialKara W Chew, Carlee Moser, Eunice Yeh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 2, 2025
Serum Biomarkers in Advanced-Stage AIDS-Associated Kaposi Sarcoma in Resource Limited SettingsMarta Epeldegui, Carlee Moser, Younjung Choi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2015
Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260sTheodoros Kelesidis, Thuy Tien T Tran, James H Stein, et al.
The Journal of Infectious Diseases|March 7, 2023
Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral TherapyElizabeth Hastie, Carlee Moser, Xin Sun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 2024
Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER StudyGrace L Ditzenberger, Jordan E Lake, Douglas W Kitch, et al.
Scientific Reports|March 20, 2026
Association of long COVID with health-related quality-of-life outcomesMalini M Gandhi, Carlee Moser, Judith S Currier, et al.
Annals of Internal Medicine|February 21, 2023
Symptom and Viral Rebound in Untreated SARS-CoV-2 InfectionRinki Deo, Manish C Choudhary, Carlee Moser, et al.
Pageof 7